Clariant : Q3 EBITDA -7% vs css due to a CHF 10m restructuring provision. FY sales outlook cut, EBITDA margin maintained, -3% d/s to css. CMD 4 November
>Organic sales down by 3% y-o-y fuelled by 3% lower volumes - Organic sales down by 3% y-o-y fuelled by 3% lower volumes in Q3 2024 (Q2 2024: 0%) and flat% y-o-y prices (Q2 2024: -3%) as well as 3% forex headwinds pushing sales down by 4% y-o-y to CHF 991m (cons./ODDO BHF CHF 1,010m/CHF 992m). The main drag on volumes was the continuing weakness of the catalysts business, showing a -20% y-o-y volume decline in Q3 (Q2 2024: -18% y-o-y) against a high comparison base. ...Clariant is a specialty chemicals group based in Switzerland. Co. develops, manufactures, distributes and sells a broad range of specialty chemicals which play a key role in its customers' manufacturing and treatment processes or add value to their end products. Co. has manufacturing plants around the world and sells mainly in countries within Europe, the Americas and Asia. Co.'s businesses are organized into four business areas: Care Chemicals (BU Industrial & Consumer Specialties), Catalysis & Energy (BU Catalysts, Business Line Energy Storage), Natural Resources (BU Oil & Mining Services, BU Functional Minerals), and Plastics & Coatings (BU Additives, BU Masterbatches, BU Pigments).
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.